Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 3021)

Milan, Milano 20133

1 studies enrolling now · 1 studies all time

What they study most

Malignant Melanoma

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) — Recruiting now